Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hacein-Bey, H
Right arrow Articles by De Saint Basile, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hacein-Bey, H
Right arrow Articles by De Saint Basile, G
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function

H Hacein-Bey, M Cavazzana-Calvo, F Le Deist, A Dautry-Varsat, C Hivroz, I Riviere, O Danos, JM Heard, K Sugamura, A Fischer and G De Saint Basile

Institut National de la Sante et de la Recherche Medicale U429, Hopital Necker-Enfants Malades, Paris, France.

SCID X1 is characterized by faulty T-cell and natural killer cell differentiation caused by mutation of the gamma-c chain gene encoding a number of multiple cytokine receptors (interleukin-2 [IL-2], IL-4, IL- 7, IL-9, and IL-15 receptors). To assess the feasibility of inducing long-term expression and function of the gamma-c chain, Epstein-Barr virus (EBV)-transformed B-cell lines from two patients with SCID X1 were transduced with a Moloney-derived retroviral vector containing the gamma-c chain cDNA. The viral LTR was used as the promoter. Immediately after two cycles of coculture with the psi-crip clone producing the MFG(B2)-gamma-c cDNA vector, gamma-c expression, assessed by detection of the mRNA and membrane protein expression, was found in 15% to 20% of cells. The degree of membrane expression was similar to that in control EBV-B cells. Expression increased steadily over 6 months, becoming detectable in 100% of cells, and remained stable thereafter for a total of 9 months, reflecting positive selection of transduced cells. A study of provirus integration sites showed multiple integration. The expressed gamma-c was functional, because it restored high-affinity IL- 2 receptor binding, IL-2 endocytosis, and IL-2-triggered phosphorylation of JAK-3 tyrosine kinase. Similar results were obtained with the two B-cell lines. These results show that efficient gamma-c gene transfer into B-cells lacking functional gamma-c is feasible and results in strong and stable expression of a functional gamma-c chain, apparently conferring a selective growth advantage in culture. Further in vitro studies of gamma-c gene transfer into gamma-c- hematopoietic progenitors are being conducted to assess the feasibility of correcting lymphocyte differentiation defects.

Volume 87, Issue 8, pp. 3108-3116, 04/15/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
C. Lagresle-Peyrou, F. Yates, M. Malassis-Seris, C. Hue, E. Morillon, A. Garrigue, A. Liu, P. Hajdari, D. Stockholm, O. Danos, et al.
Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity
Blood, January 1, 2006; 107(1): 63 - 72.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, et al.
LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Science, October 17, 2003; 302(5644): 415 - 419.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. D. Cooper, L. L. Lanier, M. E. Conley, and J. M. Puck
Immunodeficiency Disorders
Hematology, January 1, 2003; 2003(1): 314 - 330.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. J. Tsai, H. L. Malech, M. R. Kirby, A. P. Hsu, N. E. Seidel, C. D. Porada, E. D. Zanjani, D. M. Bodine, and J. M. Puck
Retroviral transduction of IL2RG into CD34+ cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras
Blood, June 17, 2002; 100(1): 72 - 79.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. May, S. Rivella, A. Chadburn, and M. Sadelain
Successful treatment of murine beta -thalassemia intermedia by transfer of the human beta -globin gene
Blood, March 15, 2002; 99(6): 1902 - 1908.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Bani, V. Pasquier, M. Kryworuchko, J. Salamero, and J. Theze
Unstimulated Human CD4 Lymphocytes Express a Cytoplasmic Immature Form of the Common Cytokine Receptor {{gamma}}-Chain
J. Immunol., July 1, 2001; 167(1): 344 - 349.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Otsu, K. Sugamura, and F. Candotti
Lack of dominant-negative effects of a truncated {gamma}c on retroviral-mediated gene correction of immunodeficient mice
Blood, March 15, 2001; 97(6): 1618 - 1624.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Soudais, T. Shiho, L. I. Sharara, D. Guy-Grand, T. Taniguchi, A. Fischer, and J. P. Di Santo
Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer
Blood, May 15, 2000; 95(10): 3071 - 3077.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. Cavazzana-Calvo, S. Hacein-Bey, G. d. S. Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J. Casanova, et al.
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Science, April 28, 2000; 288(5466): 669 - 672.
[Abstract] [Full Text]


Home page
BloodHome page
M. Lo, M. L. Bloom, K. Imada, M. Berg, J. M. Bollenbacher, E. T. Bloom, B. L. Kelsall, and W. J. Leonard
Restoration of Lymphoid Populations in a Murine Model of X-Linked Severe Combined Immunodeficiency by a Gene-Therapy Approach
Blood, November 1, 1999; 94(9): 3027 - 3036.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Hacein-Bey, G. D. S. Basile, J. Lemerle, A. Fischer, and M. Cavazzana-Calvo
gamma c Gene Transfer in the Presence of Stem Cell Factor, FLT-3L, Interleukin-7 (IL-7), IL-1alpha , and IL-15 Cytokines Restores T-Cell Differentiation From gamma c(-) X-Linked Severe Combined Immunodeficiency Hematopoietic Progenitor Cells in Murine Fetal Thymic Organ Cultures
Blood, December 1, 1998; 92(11): 4090 - 4097.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Whitwam, M. E. Haskins, P. S. Henthorn, J. N. Kraszewski, S. E. Kleiman, N. E. Seidel, D. M. Bodine, and J. M. Puck
Retroviral Marking of Canine Bone Marrow: Long-Term, High-Level Expression of Human Interleukin-2 Receptor Common Gamma Chain in Canine Lymphocytes
Blood, September 1, 1998; 92(5): 1565 - 1575.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. David, L. Bani, J.-L. Moreau, C. Demaison, K. Sun, O. Salvucci, T. Nakarai, M. de Montalembert, S. Chouaib, M. Joussemet, et al.
Further Analysis of Interleukin-2 Receptor Subunit Expression on the Different Human Peripheral Blood Mononuclear Cell Subsets
Blood, January 1, 1998; 91(1): 165 - 172.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. M. Puck, A. E. Pepper, P. S. Henthorn, F. Candotti, J. Isakov, T. Whitwam, M. E. Conley, R. E. Fischer, H. M. Rosenblatt, T. N. Small, et al.
Mutation Analysis of IL2RG in Human X-Linked Severe Combined Immunodeficiency
Blood, March 15, 1997; 89(6): 1968 - 1977.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020